Politics ❯U.S. Administration ❯Trade Policy

Tariffs

Impact on Canada Corporate Tax Rates Donald Trump

Pfizer Considers Relocating Overseas Manufacturing to U.S. Facilities

CEO Albert Bourla outlines contingency plans as Trump administration threatens 25% tariffs on imported pharmaceuticals.

Canadian Business and Consumer Confidence Rises, But U.S. Tariff Threats Loom